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This work reports on a simple and feasible ﬂuorescence resonance energy transfer (FRET) assay for
detecting reactive oxygen species (ROS) both in solution and living cell using polydopamine nanoparticle
(PDA NP) as energy acceptor and Cy5 labeled single-stranded DNA (Cy5-ssDNA) as energy donor. The
Cy5-ssDNA and PDA NPs form self-assembled conjugates (Cy5-ssDNA-PDA NP conjugates) via p-stacking
interactions. In the presence of ROS, the PDA NP adsorbed Cy5-ssDNAs can be effectively cleaved, result-
ing in the release of Cy5 molecules into solution and recovery of ﬂuorescence emission of Cy5. In order to
obtain ROS solution, the glucose oxidase-catalyzed oxidation reaction of glucose with O2 is employed to
generate hydrogen peroxide for Fenton-like reaction. The formation of ROS in Fenton-like reaction can be
detected as low as glucose oxidase-catalyzed oxidation of 100 pM glucose by the Cy5-ssDNA-PDA NP
conjugate-based FRET assay. The recovery ratio of Cy5 ﬂuorescence intensity is increased linearly with
logarithm of glucose concentration from 100 pM to 1 lM, demonstrating that the FRET assay has wide
dynamic range. In particular, intracellular ROS has been successfully detected in chemical stimulated
HepG-2 cells by the Cy5-ssDNA-PDA NP conjugate-based FRET assay with a ﬂuorescence microscopy,
indicating that this approach has great potential to monitor ROS in living cells.
 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
As biochemistry mediators of cellular pathology, reactive oxy-
gen species (ROS) including superoxide (O2), singlet oxygen (O21),
hydrogen peroxide (H2O2), hydroxyl radical (OH), hypochlorite
(ClO) and peroxynitrite (ONOO) play key roles in metabolic pro-
cesses [8]. In normal aerobic cells, ROS level is normally adjusted
by biochemical antioxidants [5]. Overaccumulation of ROS can
induce oxidative stress, which is related to many diseases such
as diabetes, cancer and molecular neurodegenerative disorders
[2,10,24]. Several techniques/assays have been used to determi-
nate ROS including electron spin resonance (ESR) spectroscopy,
ﬂuorescence spectroscopy, chemiluminescence assay and electro-
chemical biosensors [1,16,17,28,3]. Among of these methods, ﬂuo-
rescence-based assays can be used for real-time monitoring ROS
level in cells and tissues [4,11,9].
Recently, due to the unique physicochemical properties,
excellent biocompatibility and biodegradability, polydopamine
nanoparticles (PDA NPs) have attracted much attention andbeen extensively investigated for various applications includ-
ing surface modiﬁcation, bio-inspired hydrogel generation, bio-
sensor fabrication, metal deposition and drug delivery
[21,18,20,31,13,32,30,26,22,14]. Especially, it was found that
the ﬂuorescence quenching capacity of PDA NPs was equivalent
to that of graphene oxide [23]. For instance, PDA NP-based FRET
assay has been used to detect DNA and thrombin [18,20,23].
The PDA NP-based FRET assay is fast, simple and homogeneous,
and could be used for in vivo ﬂuorescence imaging.
In this paper, we developed a ‘‘light on’’ assay for detecting ROS
through FRET between PDA NP (acceptor) and Cy5 labeled ssDNA
(Cy5-ssDNA, donor). The Cy5-ssDNA and PDA NPs form self-assem-
bled conjugates (Cy5-ssDNA-PDA NP conjugates) via p-stacking
interactions, leading to signiﬁcantly quenching of ﬂuorescence of
Cy5. The ﬂuorescence of Cy5 can be restored by the decomposition
of Cy5-ssDNA-PDA NP conjugates through the ROS cleavage of
ssDNA. The capacity of the Cy5-ssDNA-PDA NP conjugate-based
FRET assay has been demonstrated by detection of Fenton-like
reaction generated ROS in solution and intracellular ROS of
chemical stimulated HepG-2 cells. To the best of our knowledge,
this is the ﬁrst example of using ﬂuorescence quenching property
of PDA NPs for monitoring intracellular ROS level.
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2.1. Materials and reagents
Dopamine hydrochloride and ammonia aqueous (NH4H2O,
28–30%) solution were purchased from Alfa Aesar (USA). Synthetic
oligonucleotide 50-TTTTTAGATACTATAT-Cy5-30 was supplied by
Sangon Ltd. (Shanghai, China). The concentration of DNA was
determined by measurement of UV absorbance at 260 nm. Glucose,
glucose oxidase (GOD) and Iron (II) sulfate heptahydrate (FeSO4
7H2O) were purchased from Sigma–Aldrich (USA). Butylated
hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) were
purchased from Aladdin Industrial Corporation (Shanghai, China).
HepG-2 cell line was obtained from Shanghai cell bank of Chinese
Academy of Science (Shanghai, China). Dulbecco’s modiﬁed Eagle’s
medium (DMEM) and fetal bovine serum (FBS) were obtained from
HyClone (USA). Phorbol-12-Myristate-13-Acetate (PMA) was
purchased from Beyotime Institute of Biotechnology (Jiangsu,
China). All other chemicals were analytical grade. Milli-Q water
(18.2 MO cm) was used in all experiments.
2.2. Instrumentation
Fluorescent emission spectra were recorded on a QE65 Pro ﬁber
optic spectrometer (Ocean Optics, USA). Laser scanning confocal
ﬂuorescence microscope (ZEISS LSM 780, Germany) was used for
living cell imaging. Transmission electron microscopy (TEM)
micrographs were obtained on a Hitachi H-600 transmission elec-
tron microscope (Hitachi, Japan) with an accelerating voltage of
100 kV. Scanning electron microscopy (SEM) measurements were
made on a XL30 ESEM FEG scanning electron microscope at an
accelerating voltage of 20 kV (FEI, USA). UV–visible spectra were
obtained by Mini 1240 UV–visible spectrophotometer (Shimadzu,
Japan). The Fourier transform infrared (FTIR) spectra were recorded
on a Bruker Vertex 70 spectrometer (Bruker, Germany). Raman
spectra were recorded on a J-Y T64000 Raman spectrometer withFig. 1. (a) TEM micrograph, (b) FTIR spectrum, (c) UV–visible spectrum and (d) Raman sp
have also been shown in the ﬁgure, respectively. The scale bar of (a) is 1 lm.514.5 nm wavelength incident laser (J-Y, France). X-ray photoelec-
tron spectra (XPS) measurements were conducted with a VG
ESCALLAB MKII spectrometer (VG, UK). Dynamic light scattering
(DLS) experiments were carried out on a Malvern Nano-ZS Zetasiz-
er (Malvern, UK).
2.3. Preparation of PDA NPs
The PDA NPs were synthesized according to a previous report
with slight modiﬁcation [19]. Brieﬂy, 0.5 mL NH4H2O was mixed
with 10 mL ethanol and 22.5 mL H2O under mild stirring at 30 C
for 30 min. Then, a total of 0.125 g dopamine hydrochloride was
dissolved in 2.5 mL H2O and immediately injected into reaction
mixture. The reaction mixture was stirred at 30 C for another
24 h. The as-prepared PDA NPs were washed with 25 mL H2O
(3 times) and collected by centrifugation (9000 rpm).
In order to obtain pure Cy5-ssDNA-PDA NP conjugates for intra-
cellular ROS detection, 14 lL Cy5-ssDNA (1.44 lM) with 2 lL PDA
NPs (2 mg/mL) were mixed in 184 lL PB (10 mM, pH 7.0) and incu-
bated at 30 C for 1 h. Subsequently Cy5-ssDNA-PDA NP conjugates
were puriﬁed by centrifugation (9000 rpm, 3 times) and re-
dispersed in 200 lL PB.
2.4. Sensing and inhibition assay of ROS
Detection of Fenton-like reaction generated ROS. Typically,
3 lL of 2 mg/mL PDA NPs solution was incubated with 20 lL
of 1.44 lM Cy5-ssDNA in 147 lL PB at 30 C for 1 h. Subse-
quently, varying concentrations of glucose solution, 6.3 U GOD
and 30 lL of 30 lM FeSO4 solution were added into the reaction
mixture, respectively. The total volume of the reaction mixture
was adjusted to 300 lL by PB and the solution was incubated
under O2 atmosphere at 30 C for another 5 min. Finally, the
ﬂuorescence spectra of the mixture were recorded on a QE65
Pro ﬁber optic spectrometer at the excitation wavelength of
633 nm.ectrum of as-prepared PDA NPs. For comparison, the spectra of dopamine monomer
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desired concentrations were added into 140 lL Cy5-ssDNA-PDA
NP conjugates solution (1.44 lM Cy5-ssDNA and 2 mg/mL PDA
NPs in PB). After incubation at 30 C for 1 h, 30 lL of 20 nM glucose,
6.3 U GOD and 30 lL of 30 lM Fe2+ were added into the reaction
mixture, respectively. Then, the reaction mixtures were treated
as previously described.
2.5. Cell culture and MTT assay
HepG-2 cell line was cultured in DMEM supplemented with 10%
FBS and 100 U/mL penicillin–streptomycin at 37 C in humidiﬁed
air with 5% CO2. The cytotoxicity of PDA NPs and Cy5-ssDNA-
PDA NP conjugates were evaluated by a traditional [3-(4,5-dimeth-
ylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] (MTT) assay.
Generally, HepG-2 cells were seeded at a density of 8  103 cellsScheme 1. The schematic representation of the FRET assay with Cy5-ssDNA and
PDA NPs as the energy donor–acceptor pair for ROS detection. The illustration is not
drawn to scale.
Fig. 2. Effects of (a) quenching time and (b) concentration of Cy5-ssDNA on quenching e
(d) GOD concentration and (e) Fe2+ concentration on the recovery ratio of Cy5 ﬂuorescenc
conducted in PB under excitation at 633 nm.per well in 96-well plate and incubated for 12 h. The culture med-
ium was removed and the cells were washed by 100 lL PBS
(10 mM PB supplemented with 0.137 M NaCl, pH 7.4, 3 times).
Then, the cells were incubated in fresh culture medium containing
different concentrations of PDA NPs and Cy5-ssDNA-PDA NP conju-
gates for another 24 h. Subsequently, the cells were washed with
100 lL PBS (3 times) and treated with 10 lL of MTT (5 mg/mL)
for 4 h. Finally, the supernatant was discharged, and purple forma-
zan product was dissolved by DMSO (100 lL per well) with gentle
shaking for 10 min. The absorbance of each well was read on a
Power Wave XS 2 Microplate Spectrophotometer at 510 nm. The
relative cell viabilities (%) were calculated by using the optical den-
sities with respect to the control value. HepG-2 cells cultured with-
out NPs were used as control sample.2.6. Intracellular imaging
The cells were seeded at a density of 1.5  105 cells per well in
six-well culture plate with 22 mm  22 mm glass coverslip at the
bottom of well and grown in fresh culture medium for 24 h. Then,
supernatant was discharged and fresh culture medium containing
20 lg/mL Cy5-ssDNA-PDA NP conjugates was introduced into the
wells and incubated for another 24 h. Finally, the cells were
washed and imaged by ZEISS LSM 780 Laser scanning confocal
ﬂuorescence microscope. For PMA stimulation, the cells were incu-
bated with 3 lM PMA in 1.5 mL culture medium for another
30 min before ﬂuorescence imaging.fﬁciency in the presence of 20 lg/mL PDA NPs. Effects of (c) cleavage/reaction time,
e intensity. The concentration of glucose in (d) and (e) is 2 nM. All experiments were
Fig. 3. (a) The ﬂuorescence spectra of Cy5 in the presence of various concentrations of glucose. (b) The calibration curve of recovery ratio of Cy5 ﬂuorescence intensity versus
logarithmic concentration of glucose. The Error bars mean standard deviations (n = 3). All experiments were conducted in PB under excitation at 633 nm.
Fig. 4. Recovery ratio of Cy5 ﬂuorescence intensity plotted as the function of
concentration of (a) thiourea, (b) BHA and (c) BHT, respectively. The Error bars
mean standard deviations (n = 3). All experiments were conducted in PB under
excitation at 633 nm.
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3.1. Characterization of the as-prepared PDA NPs
The PDA NPs are synthesized by literature reported strategy
with slight modiﬁcation [19]. The average size of the as-prepared
PDA NPs is 160 nm in diameter (as shown in Fig. 1a and Fig. S1),
respectively. The characteristic bands of several groups including
C@C, N–H and C–N are clearly observed in the FTIR spectrum of
PDA NPs (as shown in Fig. 1b). The FTIR experimental result indi-
cates that PDA NP is a p-rich and nitrogen-containing polymer
[29]. Therefore, the PDA NP can strongly adsorb ssDNA on its sur-
face via p–p stacking interactions between unpaired DNA bases
and PDA NP. The UV–visible spectrum of PDA NPs exhibits broad
band absorption which leads to a spectral overlap with the ﬂuores-
cence emission spectra of many ﬂuorophores (as shown in Fig. 1c).
The phenomenon suggests that PDA NP can be used as a broad
spectrum of FRET acceptor. In addition, Raman and XPS measure-
ments give a further conﬁrmation of successful preparation of
PDA NPs (as shown in Fig. 1d, Fig. S2) [19].
The as-prepared PDA NPs can be re-dispersed in different media
(e.g., H2O, PB, DMEM supplemented with 10% FBS and human
serum) and stored under chamber conditions for 24 h without sig-
niﬁcant aggregation (as shown in Fig. S3 and Table S1). The exper-
iment results indicate that the as-prepared PDA NPs have good
colloidal stabilities. After incubated with Cy5-ssDNA, the hydrody-
namic size of PDA NPs is slightly increased (as shown in Table S1).
The experimental result indicates that Cy5-ssDNA have been suc-
cessfully conjugated on the PDA NP surface.
3.2. Principle of the FRET assay
Scheme 1 outlines the principle of the ‘‘light on’’ FRET assay for
detecting ROS. The Cy5-ssDNA and PDA NPs form Cy5-ssDNA-PDA
NP conjugates via p-stacking interactions. Upon binding with PDA
NP, the ﬂuorescence emission of Cy5-ssDNA decreases, consistent
with the energy transfer from Cy5 to PDA NP. In the presence of
ROS, the ssDNAs take place irreversible self-cleavage, leading to
decompose Cy5-ssDNA-PDA NP conjugates. Following decomposi-
tion of Cy5-ssDNA-PDA NP conjugates, Cy5 molecules are released
from PDA NP surfaces and the ﬂuorescence emission of Cy5 is
recovered.
3.3. Sensing and inhibition assay of ROS
Several parameters, including the quenching time, the concen-
trations of Cy5-ssDNA, GOD and Fe2+, and reaction/cleavage time
were investigated systematically to establish optimized conditions
for the ROS detection by monitoring the quenching efﬁciency (QE)
and recovery ratio of Cy5 ﬂuorescence intensity (FR). Here,
Fig. 5. Confocal ﬂuorescence microscopy images (bright ﬁeld (BF, left), dark ﬁeld (DF, middle) and merging (merge, right) images) of Cy5-ssDNA-PDA NP conjugate-stained
HepG-2 cells (a) before and (b) after PMA simulation, respectively. The scale bars are 20 lm.
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cence intensities of Cy5-ssDNAwith or without PDA NPs, and F rep-
resents solution ﬂuorescence intensity in the presence of ROS,
respectively. The QE is increased with increasing the concentration
of PDA NPs (as shown in Fig. S4). However, both of the PDA NPs and
Cy5-ssDNA-PDA NP conjugates show moderate cytotoxicity while
their concentration is more than 40 lg/mL (as shown in Fig. S5).
Therefore, 20 lg/mL PDA NP is used in the FRET assay. As shown
in Fig. 2, the experimental results show that the best quenching
time, Cy5-ssDNA concentration, Fe2+ concentration, GOD concen-
tration and reaction/cleavage time are 60 min, 96 nM, 3 lM, 6.3 U
and 5 min for this FRET assay, respectively. In the following study,
all the experiments are carried out under the optimized conditions.
The analytical performance of the FRET assay was tested by
detection of Fenton-like reaction generated ROS (corresponding
reaction process is shown in Fig. S6) [7]. In this case, the ROS level
in solution is strongly dependent on the glucose concentration
since hydrogen peroxide is formed by glucose oxidase-catalyzed
oxidation reaction of glucose. As expected, the ﬂuorescence inten-
sity is increased with increasing the concentration of glucose. The
increase of FR is linear with the logarithm of glucose concentration
in the range from 100 pM to 1 lM (FR = 0.0144 lgCglucose + 0.2113,
R2 = 0.97; as shown in Fig. 3). The experimental result indicates
that the proposed FRET assay has relatively high sensitivity and
wide dynamic range for ROS detection.
The performance of the FRET assay was also tested by monitor-
ing the changes of FR with the addition of potential interferences
(the ions and molecules (e.g., Ca2+, Fe3+, Zn2+ and amino acids)
may coexist with ROS in practical samples) because the DNA cleav-
age efﬁciency of ROS could be disturbed by these interferences. As
expect, the FR is decreased by adding interference except Fe3+ (as
shown in Fig. S7). The phenomenon may caused by Fe3+ accelera-
tion of Fenton-like reaction, leading to generate additional ROS.
The experimental results indicate that the Cy5-ssDNA-PDA NP con-
jugate-based FRET assay can be used to detect ROS in the presence
of high concentration of interferences.The interaction of Cy5-ssDNA with ROS has also been investi-
gated by circular dichroism (CD) spectroscopy because CD spec-
trum can accurately characterize the DNA structure [12,27,25].
The absorption at 278 nm is decreased dramatically when Cy5-
ssDNA is co-incubated with GOD, Fe2+ and glucose (as shown in
Fig. S8). The experimental result demonstrates that Cy5-ssDNA is
cleaved by Fenton-like reaction generated ROS.
In order to further verify the utility of the FRET assay, the efﬁ-
ciencies of three potential antioxidants (thiourea, BHA and BHT)
have been measured. The antioxidants can inhibit the activity of
ROS and disrupt the ROS-ssDNA interactions. Fig. 4 shows the
inhibitory curves of the antioxidants. As expected, the FR is
decreased with increasing the concentration of antioxidant. The
half maximal inhibitory concentrations (IC50) of antioxidants fol-
low the order of BHT (0.26 mM) < BHA (0.34 mM) < thiourea
(1.03 mM), which is consistent with the results of literature reports
[15]. The results suggest that our method has the potential to
screen antioxidants and yield quantitative data on the antioxidant
capacities of different chemicals.
3.4. Living cell imaging of ROS
The intracellular ROS level has also been examined by the
Cy5-ssDNA-PDA NP conjugate-based FRET assay for proving practi-
cal application of this assay in biological samples. As a well known
stimulant, PMA has been used to stimulate HepG-2 cells in this
experiment. PMA can stimulate cell immune system to produce
large amount of ROS [4,33,6]. In this case, HepG-2 cells were
ﬁrst incubated with Cy5-ssDNA-PDA NP conjugates in serum-
supplemented cell culture medium at 37 C for 24 h. The
Cy5-ssDNA-PDA NP conjugate-stained cells show low levels of
intracellular ﬂuorescence (as shown in Fig. 5a). Upon stimulation of
Cy5-ssDNA-PDA NP conjugate-stained cells with PMA, the intracel-
lular ﬂuorescence intensity is increased signiﬁcantly (as shown in
Fig. 5b). The experimental result indicates that the FRET assay has
the great potential for monitoring the ROS ﬂuctuation in living cell.
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In summary, a simple and feasible Cy5-ssDNA-PDA NP conju-
gate-based FRET assay has been successfully developed for detect-
ing ROS through FRET between PDA NPs and Cy5-ssDNA. The
Cy5-ssDNA-PDA NP conjugates provide an excellent example for
detecting biologically active substances with relatively low limit
of detection (LOD) in the bioanalytical/biomedical applications of
PDA NPs. Although PMA simulated HepG-2 cell and Fenton-like
reaction generated ROS are chosen here to establish this new
PDA NP-based FRET assay by proof of principle experiment, our
approach is readily transferable to real analytical problems such
as monitoring ROS level in cells or body ﬂuids. Furthermore, our
approach could be extended to test the clinical efﬁcacies of natural
products or drugs in terms of their antioxidant content.Conﬂict of interest
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